Arnout Ploos van Amstel
Fortuna: 543 000 $ al 31/07/2026
Fortuna: 543 000 $ al 31/07/2026
Arnout Ploos van Amstel is the founder of Apaxcel Life Sciences GmbH, founded in 2019, serving as Consultant.
Mr. van Amstel was the founder of MoonLake Immunotherapeutics, founded in 2020, serving as Chief Operating Officer from 2020 to 2021.
Former jobs include President, Managing Director & Vice President at Novartis Corp.
from 2010 to 2019 and Independent Director at Zura Bio Ltd. from 2023 to 2025.
Education includes graduate studies at the University of Groningen.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ZURA BIO LIMITED CLASS A 0,11 % | 21/05/2025 | 100.000 ( 0,11 % ) | 543 000 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|
| Empresas | Cargo | Fin |
|---|---|---|
| ZURA BIO LIMITED | Director/Miembro de la Junta | 11/12/2025 |
| MOONLAKE IMMUNOTHERAPEUTICS | Fundador | 13/12/2021 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Presidente | 01/03/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
University of Groningen
University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Zura Bio Ltd.
Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.